<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02511561</url>
  </required_header>
  <id_info>
    <org_study_id>201-201506</org_study_id>
    <nct_id>NCT02511561</nct_id>
  </id_info>
  <brief_title>OTO-201 for the Treatment of Otitis Externa</brief_title>
  <official_title>A 1-Month, Prospective, Multicenter, Open-Label Study of OTO-201 Given as a Single Administration for Treatment of Otitis Externa</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Otonomy, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Otonomy, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a 1-month, multicenter, open-label study in subjects with unilateral otitis externa.
      Eligible subjects will receive a single dose of 6 mg OTO-201 to the affected ear. The study
      is designed to characterize safety, procedural factors and clinical effect of OTO-201
      administered in subjects with otitis externa.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2015</start_date>
  <completion_date type="Actual">November 2015</completion_date>
  <primary_completion_date type="Actual">November 2015</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Safety as assessed by adverse events</measure>
    <time_frame>Up to 1 month</time_frame>
    <description>Evaluation of adverse events</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Safety as assessed by otoscopic exams</measure>
    <time_frame>Up to 1 month</time_frame>
    <description>Evaluation of otoscopic exams</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Feasibility of administration</measure>
    <time_frame>Day1</time_frame>
    <description>Questionnaire</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical effect as assessed signs and symptoms of otitis externa</measure>
    <time_frame>Up to Two Weeks</time_frame>
    <description>Assessment of signs (edema, erythema, otorrhea) and symptoms (otalgia, tenderness)</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">75</enrollment>
  <condition>Otitis Externa</condition>
  <arm_group>
    <arm_group_label>0.1 mL OTO-201</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ciprofloxacin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>0.2 mL OTO-201</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ciprofloxacin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>0.4 mL OTO-201</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ciprofloxacin</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>OTO-201 (ciprofloxacin)</intervention_name>
    <arm_group_label>0.1 mL OTO-201</arm_group_label>
    <arm_group_label>0.2 mL OTO-201</arm_group_label>
    <arm_group_label>0.4 mL OTO-201</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria includes, but is not limited to:

          -  Subject is a male or female aged 6 months to 80 years, inclusive

          -  Subject has a clinical diagnosis of unilateral otitis externa

          -  Subject or subject's caregiver is willing to comply with the protocol and attend all
             study visits

        Exclusion Criteria includes, but is not limited to:

          -  Subject has tympanic membrane perforation

          -  Subject has a history of known immunodeficiency disease

          -  Subject has fungal otitis externa, based on clinical signs
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carl LeBel, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Otonomy, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Email Otonomy Central Contact for Trial Locations</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92121</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 28, 2015</study_first_submitted>
  <study_first_submitted_qc>July 28, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 30, 2015</study_first_posted>
  <last_update_submitted>January 21, 2016</last_update_submitted>
  <last_update_submitted_qc>January 21, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 25, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Otitis externa</keyword>
  <keyword>Swimmer's ear</keyword>
  <keyword>Ear infection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Otitis</mesh_term>
    <mesh_term>Otitis Externa</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ciprofloxacin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

